GlaxoSmithKline LLC v. FibroGen, Inc. > Summary
Court Case Number IPR2016-01318
Filing Date Jun 30, 2016
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesSusan L. C. Mitchell, Sheridan K. Snedden, Toni R. Scheiner
Judge Writing the Final DecisionSusan L. C. Mitchell
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9
Petitioner
Patent Owner
Petitioner Attorneys
3GlaxoSmithKline
Attorney Name: Jonathan S. Kim
Mayer Brown
GlaxoSmithKline
Attorney Name: Brian W. Nolan
Mayer Brown
GlaxoSmithKline
Attorney Name: Lisa M. Ferri
Mayer Brown
Patent Owner Attorneys
3FibroGen
Attorney Name: Todd R. Walters
Buchanan Ingersoll & Rooney PC
FibroGen
Attorney Name: Mythili Markowski
Buchanan Ingersoll & Rooney PC
FibroGen
Attorney Name: Roger H. Lee
Buchanan Ingersoll & Rooney PC
Related Patents
Doc No | Title | Issue date |
---|---|---|
08609646 | Enhanced erythropoiesis and iron metabolism | Dec 17, 2013 |